On the basis of confirmation received from its Registrar and Transfer Agent, Kfin Technologies (formerly known as Kfin Technologies), Procter & Gamble Health has confirmed that the details of securities dematerialised during the quarter ended September 30, 2024 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished to the stock exchanges where the shares of the Company are listed within the prescribed time period. The company has enclosed the copy of letter received from Kfin Technologies confirming the above.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: